A0,A0.35_Verb,A1,A2,Polarity,RelatedSentence
efforts,attract.01,significant political opposition,,Affirmative,Pfizer 's efforts to merge with British rival AstraZeneca has attracted significant political opposition . 
board,reject.01,"another takeover bid from Pfizer ,",,Affirmative,"AstraZeneca 's board has rejected yet another takeover bid from Pfizer , a move that could lead the U.S. drugmaker to abandon attempts to complete a mega - merger with its British rival . "
a move,lead.03,the U.S. drugmaker,to abandon attempts,Affirmative,"AstraZeneca 's board has rejected yet another takeover bid from Pfizer , a move that could lead the U.S. drugmaker to abandon attempts to complete a mega - merger with its British rival . "
the U.S. drugmaker,abandon.01,attempts,,Affirmative,"AstraZeneca 's board has rejected yet another takeover bid from Pfizer , a move that could lead the U.S. drugmaker to abandon attempts to complete a mega - merger with its British rival . "
latest offer of £55.00,undervalue.01,the company 's,,Affirmative,"AstraZeneca said in a statement that Pfizer 's latest offer of £55.00 ( $ 95.52 ) per share undervalues the company , and constituted only a minor improvement over the company 's previous offer . "
Pfizer ( PFE ),say.01,bid would be,,Affirmative,"Pfizer ( PFE ) said late Sunday that the new bid would be its final overture , and that it would not make a hostile bid for AstraZeneca ( AZN ) . "
Pfizer 's latest offer of # 55.00 -LRB- $ 95.52 -RRB- per share,value.01,British rival AstraZeneca,at,Affirmative,"The offer valued AstraZeneca at nearly $ 120 billion , and was a 45 % premium over the company 's share price in mid-April . "
British rival AstraZeneca,reject.01,four proposals from Pfizer,,Affirmative,AstraZeneca has now rejected four proposals from Pfizer . 
board,say.01,it was convinced,,Affirmative,The company 's board said Monday it was convinced that Pfizer 's takeover hopes were driven by potential cost savings and tax minimization . 
by,drive.02,takeover hopes,,Affirmative,The company 's board said Monday it was convinced that Pfizer 's takeover hopes were driven by potential cost savings and tax minimization . 
Pfizer 's,make.02,case,,Affirmative,"From our first meeting in January to our latest discussion yesterday , and in the numerous phone calls in between , Pfizer has failed to make a compelling strategic , business or value case , the board said . "
The company 's board,say.01,", Pfizer has failed",,Affirmative,"From our first meeting in January to our latest discussion yesterday , and in the numerous phone calls in between , Pfizer has failed to make a compelling strategic , business or value case , the board said . "
board,reveal.01,that it would only consider bids,,Affirmative,AstraZeneca 's board also revealed that it would only consider bids that were worth at least £58.85 . 
AstraZeneca 's board,consider.02,bids,,Affirmative,AstraZeneca 's board also revealed that it would only consider bids that were worth at least £58.85 . 
Pfizer 's,declare.01,the £55.00 bid,,Affirmative,"Since Pfizer has declared the £55.00 bid to be its final offer , it 's not clear whether the companies will be able to close the gap . "
the companies,close.01,the gap,,Affirmative,"Since Pfizer has declared the £55.00 bid to be its final offer , it 's not clear whether the companies will be able to close the gap . "
the companies,try.01,to engage in,,Affirmative,"We have tried repeatedly to engage in a constructive process with AstraZeneca to explore a combination of our two companies , Pfizer CEO Ian Read said before AstraZeneca rejected the latest bid . "
the companies,explore.01,a combination of,,Affirmative,"We have tried repeatedly to engage in a constructive process with AstraZeneca to explore a combination of our two companies , Pfizer CEO Ian Read said before AstraZeneca rejected the latest bid . "
CEO Ian Read,say.01,We have tried repeatedly,,Affirmative,"We have tried repeatedly to engage in a constructive process with AstraZeneca to explore a combination of our two companies , Pfizer CEO Ian Read said before AstraZeneca rejected the latest bid . "
British rival AstraZeneca,reject.01,the latest bid,,Affirmative,"We have tried repeatedly to engage in a constructive process with AstraZeneca to explore a combination of our two companies , Pfizer CEO Ian Read said before AstraZeneca rejected the latest bid . "
The potential takeover,attract.01,significant political attention,,Affirmative,"The potential takeover has attracted significant political attention , including calls in Britain for new powers that would allow the government to prevent takeovers by foreign firms in the interest of national security . "
new powers,allow.01,government to prevent takeovers by,,Affirmative,"The potential takeover has attracted significant political attention , including calls in Britain for new powers that would allow the government to prevent takeovers by foreign firms in the interest of national security . "
the government,prevent.01,takeovers,by,Affirmative,"The potential takeover has attracted significant political attention , including calls in Britain for new powers that would allow the government to prevent takeovers by foreign firms in the interest of national security . "
the deal,represent.01,the biggest foreign takeover of,,Affirmative,"AstraZeneca alone accounts for about 2 % of British exports , and the deal would represent the biggest foreign takeover of a British company . "
a deal,provide.01,a use for some of,,Affirmative,"In addition to an expanded drug portfolio -- particularly in cancer treatments -- a deal would provide a use for some of the billions in profits Pfizer holds outside the U.S. Pfizer had amassed financial assets worth nearly $ 50 billion at the end of 2013 , much of which is reported to be held overseas . "
Buying AstraZeneca and basing,allow.01,it to make use of,,Affirmative,"Buying AstraZeneca and basing the new combined group in the U.K. would allow it to make use of those funds -- for M&A , buybacks , dividends or other purposes -- without paying U.S. tax on them . "
AstraZeneca combination,cut.02,its rate of,,Affirmative,"While its headquarters would remain in New York , a Pfizer - AstraZeneca combination would be domiciled for tax purposes in the U.K. The U.K. has been steadily cutting its rate of corporate tax . "
The government,offer.01,financial incentives,,Affirmative,The government also offers financial incentives to encourage investment in scientific research and development . 
The government,encourage.02,investment in,,Affirmative,The government also offers financial incentives to encourage investment in scientific research and development . 
That,mean.01,for,,Affirmative,"That means for each £100 it spends , it can reduce the amount of profit liable to corporate tax by £130 . "
it,spend.01,each £100,,Affirmative,"That means for each £100 it spends , it can reduce the amount of profit liable to corporate tax by £130 . "
it,reduce.01,the amount of profit liable to,,Affirmative,"That means for each £100 it spends , it can reduce the amount of profit liable to corporate tax by £130 . "
Companies involved in,take.01,advantage,of,Affirmative,Companies involved in innovative R&D can also take advantage of a new measure called the patent box . 
it,reduce.01,the corporate tax rate on earnings attributable to U.K. or,,Affirmative,"Introduced in April 2013 , it will reduce the corporate tax rate on earnings attributable to U.K. or European patents to 10 % by 2017 . "
companies,employ.01,"175,000 people",,Affirmative,"Pharmaceutical , medical biotechnology and medical technology companies employ about 175,000 people , and spend more than £5 billion a year on R&D . "
companies,spend.01,on R&D,,Affirmative,"Pharmaceutical , medical biotechnology and medical technology companies employ about 175,000 people , and spend more than £5 billion a year on R&D . "
Pfizer,honor.01,pledges,to,Affirmative,"Concerns about pledges made in the heat of takeover battles have been fueled by complaints that Pfizer failed to honor pledges to Sweden 's Pharmacia in 2002 , and Kraft 's U-turn on the fate of a chocolate factory following its purchase of Cadbury in 2010 . "
a chocolate factory following,follow.01,its purchase of Cadbury,,Affirmative,"Concerns about pledges made in the heat of takeover battles have been fueled by complaints that Pfizer failed to honor pledges to Sweden 's Pharmacia in 2002 , and Kraft 's U-turn on the fate of a chocolate factory following its purchase of Cadbury in 2010 . "
Mark Thompson,contribute.01,reporting,,Affirmative,-- Mark Thompson contributed reporting . 
by,delay.01,"the DJIA ,",,Affirmative,"Market indexes are shown in real time , except for the DJIA , which is delayed by two minutes . "
by,distribute.01,Jones IndexesSM,,Affirmative,"Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company , Inc . "
by BATS,provided.01,quote data provided by BATS,,Affirmative,Most stock quote data provided by BATS . 
